Table 1.
The effects of guanosine on LPS-induced inflammatory response were independent of the adenosinergic system
| Treatment | TNF-α levels (% of control) | IL-1β levels (% of control) |
|---|---|---|
| LPS | 280 ± 18a | 190 ± 12a |
| GUO + LPS | 112 ± 12b | 110 ± 10b |
| ADO 100 + LPS | 271 ± 15a | 182 ± 12a |
| ADO 1000 + LPS | 277 ± 21a | 185 ± 15a |
| CAF 100 + LPS | 283 ± 22a | 180 ± 14a |
| CAF 1000 + LPS | 268 ± 22a | 178 ± 15a |
| GUO + CAF 100 + LPS | 115 ± 14b | 107 ± 10b |
| GUO + CAF 1000 + LPS | 114 ± 12b | 115 ± 15b |
Cells were incubated in serum-free DMEM/F12 with adenosine (100 and 1000 μM) or 100 μM guanosine (GUO) and caffeine (100 and 1000 μM) for 1 h before being treated with 10 μg/mL LPS for 3 h. TNF-α and IL-1β levels were measured as described in the “Materials and methods” section. Data represent the mean ± S.E.M. of three independent experiments that were performed in triplicate. Differences between groups were statistically analyzed using two-way ANOVA, followed by Tukey’s test. Values of P < 0.05 were considered significant
aDifferences from control conditions
bDifferences from LPS